Core Insights - FMC Corporation has received registration in Brazil for its Sofero™ Fall pheromone, targeting fall armyworm, marking a significant milestone in sustainable crop protection solutions [1][3] - Sofero™ Fall represents a novel approach to pest management, focusing on mating disruption to prevent reproduction of fall armyworm, thus enhancing crop protection [3][4] - The Sofero™ portfolio aims to address resistance challenges faced by growers, providing an integrated solution alongside traditional pest management practices [4][5] Company Overview - FMC Corporation is a global agricultural sciences company dedicated to sustainable agricultural practices, helping growers produce food, feed, fiber, and fuel [6] - The company emphasizes innovation in crop protection solutions, including biologicals and precision agriculture, to meet the challenges of a growing world population [6] Product Details - Sofero™ Fall is the first product under the Sofero™ pheromone solutions brand, targeting key crops such as rice, corn, cotton, and soybeans [4] - The product utilizes proprietary microencapsulation technology to enhance stability and effectiveness, providing longer-lasting protection for crops [3][4]

Core Viewpoint - FMC Corporation is actively engaging in the agricultural sciences sector, focusing on innovative solutions to support food production and environmental sustainability [2]. Group 1: Company Announcement - FMC Corporation will have its chairman and CEO, Pierre Brondeau, and CFO, Andrew Sandifer, speaking at the BMO Capital Markets Global Farm to Market Conference on May 15, 2025, at 9:30 a.m. Eastern Time [1]. - A live webcast of the conference will be available on FMC's investor relations website [1]. Group 2: Company Overview - FMC Corporation is dedicated to helping growers produce food, feed, fiber, and fuel for a growing global population while adapting to environmental changes [2]. - The company offers innovative crop protection solutions, including biologicals, crop nutrition, and digital agriculture, aimed at addressing economic challenges while protecting the environment [2]. - FMC is committed to discovering new active ingredients for herbicides, insecticides, and fungicides, along with product formulations and technologies that are environmentally friendly [2].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased FMC Corporation securities between November 16, 2023, and February 4, 2025, of the April 14, 2025, lead plaintiff deadline for a class action lawsuit [1] Group 1: Class Action Details - Investors who purchased FMC securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by April 14, 2025 [2] - The lawsuit alleges that FMC made false and misleading statements regarding its channel management initiatives and pricing strategies, leading to inflated inventory levels in various regions [4] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in this area [3] - The firm has secured significant settlements for investors, including over $438 million in 2019 alone, and has been consistently ranked among the top firms for securities class action settlements [3]

Core Viewpoint - FMC is positioned to potentially continue its earnings-beat streak, having a history of surpassing earnings estimates, particularly in the last two quarters with an average surprise of 26% [1]. Earnings Performance - For the last reported quarter, FMC achieved earnings of $1.79 per share, exceeding the Zacks Consensus Estimate of $1.61 per share, resulting in a surprise of 11.18% [2]. - In the previous quarter, FMC was expected to report earnings of $0.49 per share but delivered $0.69 per share, leading to a surprise of 40.82% [2]. Earnings Estimates and Predictions - Estimates for FMC have been trending higher, influenced by its history of earnings surprises, and the stock currently has a positive Zacks Earnings ESP of +25%, indicating bullish sentiment among analysts regarding its earnings prospects [5][8]. - The combination of a positive Earnings ESP and a Zacks Rank of 3 (Hold) suggests a strong likelihood of another earnings beat, with historical data showing that such combinations lead to positive surprises nearly 70% of the time [6][8]. Earnings ESP Explanation - The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate, with the Most Accurate Estimate reflecting the latest analyst revisions, which may provide a more accurate prediction of earnings [7]. Future Earnings Report - FMC's next earnings report is anticipated to be released on April 30, 2025, and the current positive indicators suggest a favorable outlook for the company [8].

Core Viewpoint - A class action securities lawsuit has been filed against FMC Corporation, alleging securities fraud that affected investors between November 16, 2023, and February 4, 2025 [1][2]. Group 1: Allegations of Fraud - The lawsuit claims that FMC Corporation made false statements regarding its channel management initiatives, which were not progressing as claimed [2]. - It is alleged that the company faced pricing pressure and chose not to compete on prices, opting to walk away from sales opportunities instead [2]. - The complaint also states that FMC inflated inventory levels in various regions, including Latin America (Brazil), Asia (India), Canada, and Eastern Europe [2]. - As a result of these actions, the positive statements made by the defendants about the company's business and prospects were misleading and lacked a reasonable basis [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until April 14, 2025, to request to be appointed as lead plaintiff in the case [3]. - Participation in the lawsuit does not require serving as a lead plaintiff, and class members may be entitled to compensation without any out-of-pocket costs [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [4]. - The firm has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased FMC Corporation securities between November 16, 2023, and February 4, 2025, of the upcoming lead plaintiff deadline on April 14, 2025, for a class action lawsuit [1] Group 1: Class Action Details - Investors who purchased FMC securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by April 14, 2025 [2] - The lawsuit alleges that FMC made false and misleading statements regarding its channel management initiatives and pricing strategies, leading to inflated inventory levels in various regions [4] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [3] - The firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time, and has consistently ranked highly in securities class action settlements since 2013 [3] - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering funds for clients [3]

Core Viewpoint - Rosen Law Firm is reminding purchasers of FMC Corporation securities about a class action lawsuit and the upcoming lead plaintiff deadline on April 14, 2025, for potential compensation without out-of-pocket fees [1][2]. Group 1: Class Action Details - The class action pertains to FMC Corporation securities purchased between November 16, 2023, and February 4, 2025 [1]. - Investors can join the class action by submitting a form or contacting the law firm directly [2][5]. - A lead plaintiff must file a motion with the court by April 14, 2025, to represent other class members [2]. Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest against a Chinese company at the time [3]. - The firm has been consistently ranked among the top firms for securities class action settlements since 2013, recovering hundreds of millions for investors [3]. - In 2019, the firm secured over $438 million for investors, showcasing its effectiveness in litigation [3]. Group 3: Case Allegations - The lawsuit alleges that FMC made false and misleading statements regarding its channel management initiatives and pricing strategies [4]. - It is claimed that FMC inflated inventory levels in various regions, including Latin America, Asia, Canada, and Eastern Europe, which misled investors about the company's operations and prospects [4]. - The lawsuit asserts that when the true information was revealed, investors suffered damages due to the misleading statements [4].

NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of FMC Corporation (NYSE: FMC). Shareholders who purchased shares of FMC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/fmc-corporation-loss-submission-form/?id=140430&from=3  CLASS PERIOD: November 16, 20 ...

Group 1 - FMC Corporation has partnered with Bayer to introduce Isoflex active herbicide technology in the EU and Great Britain, enhancing FMC's weed control technology access in European markets [1][2] - Isoflex active is classified as a Group 13 herbicide and has received registration in Great Britain for 2024, with EU registration expected in 2025 [1][2] - The herbicide targets resistant grass weeds in cereals and other crops, addressing a significant need in European agriculture, with access to approximately 30 million planted hectares of winter cereals [2][3] Group 2 - FMC plans to commercialize its formulations while Bayer will handle registrations and commercialization of mixtures containing Isoflex active, with product launches expected in Great Britain later this year and in the EU by 2027 [3] - The partnership aims to jointly promote the Isoflex active brand, contributing to food security in the region [3] Group 3 - FMC's stock has declined by 30.2% over the past year, compared to an 8.8% decline in the industry [4] - Currently, FMC holds a Zacks Rank of 5 (Strong Sell), while competitors like Ingevity Corporation and Axalta Coating Systems have better rankings [5]

Core Points - Rosen Law Firm is reminding purchasers of FMC Corporation securities from November 16, 2023, to February 4, 2025, about the April 14, 2025, lead plaintiff deadline [1] - Investors who purchased FMC securities during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] Class Action Details - A class action lawsuit has been filed against FMC Corporation, alleging that the company made false and misleading statements regarding its channel management initiatives and pricing strategies [4] - The lawsuit claims that FMC inflated inventory in various regions, including Latin America, Asia, Canada, and Eastern Europe, leading to materially misleading statements about its business and operations [4] Legal Representation - Investors are encouraged to select qualified legal counsel with a successful track record in securities class actions, as many firms may not have the necessary experience or resources [3] - Rosen Law Firm has a history of significant recoveries for investors, including over $438 million in 2019 alone, and has been recognized for its leadership in securities class action settlements [3]